NCT02986529View on ClinicalTrials.gov

A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

February 24, 2017

Study Completion Date

November 30, 2017

Conditions

Bioavailability

Interventions

DRUG

GV-971

DRUG

Placebos

Trial Locations (1)

200031

Phase-I Clinical Research Unit at Shanghai Xuhui Center hospital, Shanghai

All Listed Sponsors

lead

Shanghai Greenvalley Pharmaceutical Co., Ltd.

INDUSTRY

NCT02986529 - A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects | Biotech Hunter | Biotech Hunter